2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Annals of the Rheumatic Diseases Année : 2022

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

Annette de Thurah
Philipp Bosch
  • Fonction : Auteur
Andrea Marques
  • Fonction : Auteur
Yvette Meissner
Chetan Mukhtyar
Johannes Knitza
Aurélie Najm
Nina Østerås
Tim Pelle
  • Fonction : Auteur
Line Raunsbæk Knudsen
  • Fonction : Auteur
Hana Šmucrová
  • Fonction : Auteur
Francis Berenbaum
Meghna Jani
Rinie Geenen
  • Fonction : Auteur
Martin Krusche
Polina Pchelnikova
  • Fonction : Auteur
Savia de Souza
  • Fonction : Auteur
Sara Badreh
  • Fonction : Auteur
Dieter Wiek
  • Fonction : Auteur
Silvia Piantoni
James Gwinnutt
  • Fonction : Auteur
Christina Duftner
Helena Canhão
  • Fonction : Auteur
Luca Quartuccio
  • Fonction : Auteur
Nikolay Stoilov
  • Fonction : Auteur
Yeliz Prior
Johannes Wj Bijlsma
Alen Zabotti
Tanja Stamm
Christian Dejaco

Résumé

Background Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD). Objective To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD. Methods A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting. Results Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient’s needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible. The level of agreement to each statement ranged from 8.5 to 9.8/10. Conclusion The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.

Dates et versions

hal-03994835 , version 1 (17-02-2023)

Identifiants

Citer

Annette de Thurah, Philipp Bosch, Andrea Marques, Yvette Meissner, Chetan Mukhtyar, et al.. 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases, 2022, 81 (8), pp.1065-1071. ⟨10.1136/annrheumdis-2022-222341⟩. ⟨hal-03994835⟩
26 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More